PHE_Scientific_ Provision of NucleoCounter

As part of PHE's response to the ongoing international outbreak of a novel Corona Virus (SARS-CoV-2) Public Health England awarded a contract to Chemometec A/S for the provision of Nucleocounter as part of vitro/in vivo antiviral efficacy studies.

Additional information: PHE and its successor bodies, discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the recent COVID -19 outbreak.

PO terms and conditions were used and the attached is an example PO.